ERBB2 and neoplasm: Numerous studies assessed the prognostic significance of T-cell and B-cell cell markers, predominantly in TNBC or HER2-positive cancer, with most demonstrating improved survival with increased immune cell density; however, less data exists regarding associations with outcome in luminal tumours and local recurrence (LR) in the breast.